Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

NCT00823628 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Chronic Renal Insufficiency
Coronary Angiography

Interventions

DRUG: contrast agent (iopromide)
DRUG: contrast agent (iodixanol)

Sponsor

Seoul National University Bundang Hospital